Terns Corp (TERN) - Net earnings per one share growth for the current year

TERN (Terns Pharmaceuticals) - company brandmark

The annual evolution of earnings per share, based on GURU.Markets data, indicates that the -20.60 level serves as a critical benchmark. This trend reflects the battle for market share in obesity treatments driven by molecular safety. Current cash flow relies on grants while awaiting the commercialization of the portfolio. The scientific prestige of Terns Pharmaceuticals (TERN) is based on the development of effective oral liver therapies.

Earnings per share growth in current year: Terns Pharma (TERN) for 07/04/2022 - 05/16/2026

Analytical breakdowns and data insights for company Terns Pharma (TERN)

- share price and expert price forecast:
Price Terns Pharmaceuticals|TERN - Consensus Target
- market capitalization indicators:
Market Value Terns Pharmaceuticals|TERN - Enterprise Value
- balance sheet net asset value indicators:
Net Asset Value per Share Terns Pharmaceuticals|TERN - Company Book Value|Market Value to Book Value ternspharma.com|TERN - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Ratio Terns Pharmaceuticals|TERN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Terns Pharmaceuticals Inc|TERN - Company Total Debt|Debt to Net Assets Ratio Terns Pharmaceuticals, Inc.|TERN - Company Long-Term Debt|Current Liabilities Terns Pharmaceuticals|Intermediate Coverage Ratio ternspharma.com
- company profitability and valuation multiples indicators:
TERN - Net Profit|Projected Future Earnings Terns Pharmaceuticals|TERN - Price to Earnings Ratio|Future Price to Earnings Multiple ternspharma.com|TERN - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Terns Pharmaceuticals|TERN - Operating profit EBITDA|Net earnings per share (EPS TTM) Terns Pharmaceuticals|TERN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months ternspharma.com|TERN - Earnings growth in current year|Expected net earnings per share growth next year Terns Pharmaceuticals
- revenue and sales proceeds data:
TERN - Company Sales|Projected Sales Volume Terns Pharmaceuticals|TERN - Market Cap to Revenue|Price to Expected Revenue Ratio Terns Pharmaceuticals
Summary company analysis:Terns Corp (TERN)
Brand item of Terns Pharmaceuticals, Inc.

Professional selection of sustainable assets is based on an analysis of net profit per share dynamics. By evaluating the annual growth rate of earnings per share, an investor observes the percentage change in EPS compared to the previous period, which for Terns Pharmaceuticals (TERN) reflects progress in the development of gastrointestinal drugs and access to venture capital rather than market cyclicality.

Main competitors

PHAT: Net earnings per one share growth for the current year|IRWD (Ironwood Pharmaceuticals, Inc.) - Earnings growth in current year|Net earnings per share growth this year Curanex Pharmaceuticals (CURX)|Earnings per share growth in current year Immuron Ltd (IMRN)|Earnings per share growth in current year EVOK (Evoke Pharma Inc.)|Entero Therapeutics - Net earnings per share growth this year|RDHL: Earnings per share growth this year|Palisade Bio Inc. - Earnings growth in current year|JAGX - Earnings growth in current year|BIOR: Earnings growth in current year|Morphic - Earnings per share increase in current year